A meta-analysis of transcriptomic profiles of Huntington’s disease patients
Open Access
- 10 June 2021
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 16 (6) , e0253037
Abstract
Description of robust transcriptomic alterations in Huntington’s disease is essential to identify targets for biochemical studies and drug development. We analysed publicly available transcriptome data from the brain and blood of 220 HD patients and 241 healthy controls and identified 737 and 661 genes with robustly altered mRNA levels in the brain and blood of HD patients, respectively. In the brain, a subnetwork of 320 genes strongly correlated with HD and was enriched in transport-related genes. Bioinformatical analysis of this subnetwork highlighted CDC42, PAK1, YWHAH, NFY, DLX1, HMGN3, and PRMT3. Moreover, we found that CREB1 can regulate 78.0% of genes whose mRNA levels correlated with HD in the blood of patients. Alterations in protein transport, metabolism, transcriptional regulation, and CDC42-mediated functions are likely central features of HD. Further our data substantiate the role of transcriptional regulators that have not been reported in the context of HD (e.g. DLX1, HMGN3 and PRMT3) and strongly suggest dysregulation of NFY and its target genes across tissues. A large proportion of the identified genes such as CDC42 were also altered in Parkinson’s (PD) and Alzheimer’s disease (AD). The observed dysregulation of CDC42 and YWHAH in samples from HD, AD and PD patients indicates that those genes and their upstream regulators may be interesting therapeutic targets.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (412854449)
This publication has 88 references indexed in Scilit:
- Mechanisms of RNA-induced toxicity in CAG repeat disordersCell Death & Disease, 2013
- Robust rank aggregation for gene list integration and meta-analysisBioinformatics, 2012
- Transcriptional modulator H2A histone family, member Y ( H2AFY ) marks Huntington disease activity in man and mouseProceedings of the National Academy of Sciences, 2011
- Transcriptional changes in Huntington disease identified using genome-wide expression profiling and cross-platform analysisHuman Molecular Genetics, 2010
- Systematic behavioral evaluation of Huntington's disease transgenic and knock-in mouse modelsNeurobiology of Disease, 2009
- Mutant Huntingtin reduces HSP70 expression through the sequestration of NF‐Y transcription factorThe EMBO Journal, 2008
- Analysis of potential transcriptomic biomarkers for Huntington's disease in peripheral bloodProceedings of the National Academy of Sciences, 2007
- A Hip1R–cortactin complex negatively regulates actin assembly associated with endocytosisThe EMBO Journal, 2007
- ESET/SETDB1 gene expression and histone H3 (K9) trimethylation in Huntington's diseaseProceedings of the National Academy of Sciences, 2006
- KEGG: Kyoto Encyclopedia of Genes and GenomesNucleic Acids Research, 2000